Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Heart ischemic disease

Special risk patients Administer with caution to patients with thyroid disease, diabetes mellitus, cardiovascular disease, coronary artery disease, hypertension, peripheral vascular disease, heart disease, ischemic heart disease, increased intraocular pressure, or prostatic hypertrophy. [Pg.781]

Epidemiological evidence suggests an inverse relationship between the consumption of whole-grain foods and the relative risk of a number of chronic diseases. Studies have found that habitual consumption of whole-grain foods is associated with reductions in premature mortality, risk of coronary heart disease, ischemic stroke, and type 2 diabetes. [Pg.497]

Prior to this work, dietary fiber, of which ceUulose is oae of the more important constituents, was considered important primarily as a means of preventing or overcoming constipation. Otherwise, dietary fiber was considered to be a metaboHcally iaert substance. A large variety of diseases such as appendicitis, hiatus hernia, gallstones, ischemic heart disease, diabetes, obesity, dental caries, and duodenal ulcers are now suspected to be associated with the consumption of a highly refined diet (42). [Pg.353]

Nuclear medicine studies may reveal information that is primarily anatomic in nature, or indicate the function of an organ on a regional basis (Table 1). These studies may be intended to identify new disease, confirm or deny suspected disease, or foUow the progress of treatment or the course of disease. The diseases may be relatively benign or extremely serious and can range from widespread medical problems such as ischemic heart disease to rarities such as Legge-Perthe s disease and malignant pheochromocytoma (7). [Pg.474]

Technetium-9 9m sestamibi is used in myocardial perfusion imaging for the evaluation of ischemic heart disease. It is prepared from a lyophilized kit containing tetrakis(2-methoxy isobutyl isonittile) copper(I) tetrafluoroborate stored under nitrogen. Upon reconstitution with up to 5.6 GBq (150 mCi) of 99mTc pertechnetate, the product is formed by boiling for 10 minutes. [Pg.483]

A third study (85) enrolled 7825 hypertensive patients (55% males and 45% females) having diastoHc blood pressures (DBP) of 99—104 mm Hg (13—14 Pa) there were no placebo controls. Forty-six percent of the patients were assigned to SC antihypertensive dmg therapy, ie, step 1, chlorthaUdone step 2, reserpine [50-55-5] or methyldopa [555-30-6], and step 3, hydralazine [86-54-4]. Fifty-four percent of the patients were assigned to the usual care (UC) sources in the community. Significant reductions in DBP and in cardiovascular and noncardiovascular deaths were noted in both groups. In the SC group, deaths from ischemic heart disease increased 9%, and deaths from coronary heart disease (CHD) and acute myocardial infarctions were reduced 20 and 46%, respectively. [Pg.212]

Nowadays the one of the leading cause of death in industrial country is Heart Failure (HF). Under the pathological conditions (e.g., Ischemic Heart Disease (IHD)) the changes in the enzymes activity and ultrastructure of tissue were obtained. The behavior of trace elements may reflect the activity of different types of enzymes. Pathological changes affects only small area of tissue, hence the amount of samples is strictly limited. Thereby, nondestructive multielemental method SRXRF allow to perfonu the analysis of mass samples in a few milligrams, to save the samples, to investigate the elemental distribution on the sample area. [Pg.353]

The decongestants are used cautiously in patients with hyperthyroidism, diabetes mellitus, prostatic hypertrophy, ischemic heart disease, and glaucoma Safe use of the... [Pg.329]

About 4.5 million Americans have heart failure (HF). It is the most frequent cause of hospitalization for individuals older than 65 years. Some patients, with treatment, may lead nearly normal lives, whereas more than 50% of individuals with severe HF die each year. HF is a complex clinical syndrome that can result from any number of cardiac or metabolic disorders such as ischemic heart disease, hypertension, or hyperthyroidism. Any condition that impairs the ability of the ventricle to pump blood can lead to HF In HF, die heart... [Pg.357]

Subgroup analysis showed that all penicillin-induced deaths occurred between 60 and 74 years, whereas cephalosporin-induced deaths occurred between 35 and 74 years of age. Significant comorbidities included ischemic heart disease or dysarrhythmia, obstructive airway disease, mastocytosis and hypogammaglobulinemia. [Pg.15]

In general, treatment of the asthma underlying NSAlDs sensitivity should follow standard asthma guidelines. This type of asthma is often severe and frequently high doses of inhaled corticosteroids and daily doses of oral corticosteroids are necessary. A special treatment option is a chronic desensitization to aspirin [8]. Desensitization and aspirin maintenance is routinely used in some centers for treatment of chronic rhinusinusitis with nasal polyposis. It is the only available procedure which allows AIA patients with ischemic heart disease to use aspirin. During the state of desensitization to aspirin, not only aspirin but almost all strong NSAIDs are tolerated, so desensitization and NSAID maintenance could be used for treatment of rheumatic disease or chronic pain syndromes. [Pg.176]

Serious adverse effects of epinephrine potentially occur when it is given in an excessive dose, or too rapidly, for example, as an intravenous bolus or a rapid intravenous infusion. These include ventricular dysrhythmias, angina, myocardial infarction, pulmonary edema, sudden sharp increase in blood pressure, and cerebral hemorrhage. The risk of epinephrine adverse effects is also potentially increased in patients with hypertension or ischemic heart disease, and in those using (3-blockers (due to unopposed epinephrine action on vascular Ui-adrenergic receptors), monoamine oxidase inhibitors, tricyclic antidepressants, or cocaine. Even in these patients, there is no absolute contraindication for the use of epinephrine in the treatment of anaphylaxis [1,5,6]. [Pg.213]

Romano PS, Roos LL, Luft HS, et al. A comparison of administrative versus clinical data coronary artery bypass surgery as an example. Ischemic Heart Disease Patient Outcomes Research Team. / Clin Epidemiol 1994 47 249-60. [Pg.589]

The a-tocopherol, P-carotene (ATBC) Cancer Prevention study was a randomised-controlled trial that tested the effects of daily doses of either 50 mg (50 lU) vitamin E (all-racemic a-tocopherol acetate), or 20 mg of P-carotene, or both with that of a placebo, in a population of more than 29,000 male smokers for 5-8 years. No reduction in lung cancer or major coronary events was observed with any of the treatments. What was more startling was the unexpected increases in risk of death from lung cancer and ischemic heart disease with P-carotene supplementation (ATBC Cancer Prevention Study Group, 1994). Increases in the risk of both lung cancer and cardiovascular disease mortality were also observed in the P-carotene and Retinol Efficacy Trial (CARET), which tested the effects of combined treatment with 30 mg/d P-carotene and retinyl pahnitate (25,000 lU/d) in 18,000 men and women with a history of cigarette smoking or occupational exposure to asbestos (Hennekens et al, 1996). [Pg.33]

HERTOG M G L, SWEETNAM P M, FEHILY A M, ELWOOD P C and KROMHOUT D (1997) Antioxidant flavonols and ischemic heart disease in a Welsh population of men The Casrphilly Study , Am J Clin Nutr, 65, 1489-94. [Pg.152]

Gey, K.F. et al.. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke Basel Prospective Study, J. Clin. Invest., 71, 3, 1993. [Pg.143]

Symptoms Many patients who are hypertensive also have diabetes. The diabetic patient may be asymptomatic or may have ischemic heart disease. [Pg.14]

Identify risk factors for the development of ischemic heart disease. [Pg.63]

Recognize the symptoms and diagnostic criteria of ischemic heart disease in a specific patient. [Pg.63]

Identify the treatment goals of ischemic heart disease and appropriate lifestyle modifications and pharmacologic therapy to address each goal. [Pg.63]

Design an appropriate therapeutic regimen for the management of ischemic heart disease based on patient-specific information. [Pg.63]

Formulate a monitoring plan to assess effectiveness and adverse effects of an ischemic heart disease drug regimen. [Pg.63]

O Ischemic heart disease results from an imbalance between myocardial oxygen demand and oxygen supply that is most often due to coronary atherosclerosis. Common clinical manifestations of ischemic heart disease include chronic stable angina and the acute coronary syndromes of unstable angina, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction. [Pg.63]

Early detection and aggressive modification of risk factors is one of the primary strategies for delaying ischemic heart disease progression and preventing ischemic heart disease-related events including death. [Pg.63]

Patients with chest pressure or heaviness that is provoked by activity and relieved with rest should be assessed for ischemic heart disease. Sharp pain is not a typical symptom of ischemic heart disease. Some patients may experience discomfort in the neck, jaw, shoulder, or arm rather than, or in addition to, the chest. Pain may be accompanied by nausea, vomiting, or diaphoresis. [Pg.63]

The major goals for the treatment of ischemic heart disease are to prevent acute coronary syndromes and death, alleviate acute symptoms of myocardial ischemia, prevent recurrent symptoms of myocardial ischemia, and avoid or minimize adverse treatment effects. [Pg.63]


See other pages where Heart ischemic disease is mentioned: [Pg.454]    [Pg.569]    [Pg.454]    [Pg.973]    [Pg.337]    [Pg.246]    [Pg.454]    [Pg.569]    [Pg.454]    [Pg.973]    [Pg.337]    [Pg.246]    [Pg.353]    [Pg.122]    [Pg.212]    [Pg.79]    [Pg.402]    [Pg.574]    [Pg.269]    [Pg.103]    [Pg.582]    [Pg.15]    [Pg.26]    [Pg.27]    [Pg.34]    [Pg.42]    [Pg.50]    [Pg.63]   


SEARCH



Ischemic

Ischemic disease

© 2024 chempedia.info